Page last updated: 2024-10-28

hydroxychloroquine and Keratoconjunctivitis

hydroxychloroquine has been researched along with Keratoconjunctivitis in 2 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Keratoconjunctivitis: Simultaneous inflammation of the cornea and conjunctiva.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jones, BR1
Voop, HV1
Bonnet, M1

Other Studies

2 other studies available for hydroxychloroquine and Keratoconjunctivitis

ArticleYear
The management of keratoconjuctivitis sicca.
    Transactions of the ophthalmological societies of the United Kingdom, 1965, Volume: 85

    Topics: Anesthetics; Autoimmune Diseases; Bicarbonates; Chloramphenicol; Cysteine; Dextrans; Heparin; Herpes

1965
[Treatment of Goujerot-Sjogren syndrome].
    Annales d'oculistique, 1970, Volume: 203, Issue:8

    Topics: Antimalarials; Female; Glucocorticoids; Humans; Hydroxychloroquine; Injections; Keratoconjunctivitis

1970